245 related articles for article (PubMed ID: 35185868)
1. Utilization of Treg Cells in Solid Organ Transplantation.
Juneja T; Kazmi M; Mellace M; Saidi RF
Front Immunol; 2022; 13():746889. PubMed ID: 35185868
[TBL] [Abstract][Full Text] [Related]
2. The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations.
Terry LV; Oo YH
Front Immunol; 2020; 11():565518. PubMed ID: 33072105
[TBL] [Abstract][Full Text] [Related]
3. Notch-1 Inhibition Promotes Immune Regulation in Transplantation Via Regulatory T Cell-Dependent Mechanisms.
Magee CN; Murakami N; Borges TJ; Shimizu T; Safa K; Ohori S; Cai S; Uffing A; Azzi J; Elyaman W; Charbonnier LM; Liu K; Toprak D; Visner G; Chatila TA; Siebel CW; Najafian N; Riella LV
Circulation; 2019 Sep; 140(10):846-863. PubMed ID: 31266349
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T cells: first steps of clinical application in solid organ transplantation.
van der Net JB; Bushell A; Wood KJ; Harden PN
Transpl Int; 2016 Jan; 29(1):3-11. PubMed ID: 25981203
[TBL] [Abstract][Full Text] [Related]
5. Cell therapy in transplantation: A comprehensive review of the current applications of cell therapy in transplant patients with the focus on Tregs, CAR Tregs, and Mesenchymal stem cells.
Mansourabadi AH; Mohamed Khosroshahi L; Noorbakhsh F; Amirzargar A
Int Immunopharmacol; 2021 Aug; 97():107669. PubMed ID: 33965760
[TBL] [Abstract][Full Text] [Related]
6. Transplantation and immunosuppression: a review of novel transplant-related immunosuppressant drugs.
Parlakpinar H; Gunata M
Immunopharmacol Immunotoxicol; 2021 Dec; 43(6):651-665. PubMed ID: 34415233
[TBL] [Abstract][Full Text] [Related]
7. Regulatory T cells induce transplant immune tolerance.
Lu J; Li P; Du X; Liu Y; Zhang B; Qi F
Transpl Immunol; 2021 Aug; 67():101411. PubMed ID: 34020045
[TBL] [Abstract][Full Text] [Related]
8. Treg Therapy for the Induction of Immune Tolerance in Transplantation-Not Lost in Translation?
Pilat N; Steiner R; Sprent J
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675265
[TBL] [Abstract][Full Text] [Related]
9. Identification, selection, and expansion of non-gene modified alloantigen-reactive Tregs for clinical therapeutic use.
Alzhrani A; Bottomley M; Wood K; Hester J; Issa F
Cell Immunol; 2020 Nov; 357():104214. PubMed ID: 32977154
[TBL] [Abstract][Full Text] [Related]
10. Adoptive Transfer of Regulatory Immune Cells in Organ Transplantation.
Oberholtzer N; Atkinson C; Nadig SN
Front Immunol; 2021; 12():631365. PubMed ID: 33737934
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive T-cell antibody induction for heart transplant recipients.
Penninga L; Møller CH; Gustafsson F; Gluud C; Steinbrüchel DA
Cochrane Database Syst Rev; 2013 Dec; (12):CD008842. PubMed ID: 24297433
[TBL] [Abstract][Full Text] [Related]
12. iPSC-derived MSC therapy induces immune tolerance and supports long-term graft survival in mouse orthotopic tracheal transplants.
Khan MA; Alanazi F; Ahmed HA; Shamma T; Kelly K; Hammad MA; Alawad AO; Assiri AM; Broering DC
Stem Cell Res Ther; 2019 Sep; 10(1):290. PubMed ID: 31547869
[TBL] [Abstract][Full Text] [Related]
13. Inducing CTLA-4-dependent immune regulation by selective CD28 blockade promotes regulatory T cells in organ transplantation.
Poirier N; Azimzadeh AM; Zhang T; Dilek N; Mary C; Nguyen B; Tillou X; Wu G; Reneaudin K; Hervouet J; Martinet B; Coulon F; Allain-Launay E; Karam G; Soulillou JP; Pierson RN; Blancho G; Vanhove B
Sci Transl Med; 2010 Feb; 2(17):17ra10. PubMed ID: 20371478
[TBL] [Abstract][Full Text] [Related]
14. Tolerogenic dendritic cells suppress murine corneal allograft rejection by modulating CD28/CTLA-4 expression on regulatory T cells.
Yan F; Cai L; Hui Y; Chen S; Meng H; Huang Z
Cell Biol Int; 2014 Jul; 38(7):835-48. PubMed ID: 24604878
[TBL] [Abstract][Full Text] [Related]
15. Regulatory T-cell therapy for transplantation: how many cells do we need?
Tang Q; Lee K
Curr Opin Organ Transplant; 2012 Aug; 17(4):349-54. PubMed ID: 22790069
[TBL] [Abstract][Full Text] [Related]
16. A GMP Protocol for the Manufacture of Tregs for Clinical Application.
O'Neil A; Brook M; Abdul-Wahab S; Hester J; Lombardi G; Issa F
Methods Mol Biol; 2023; 2559():205-227. PubMed ID: 36180635
[TBL] [Abstract][Full Text] [Related]
17. FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance.
Dummer CD; Carpio VN; Gonçalves LF; Manfro RC; Veronese FV
Transpl Immunol; 2012 Jan; 26(1):1-10. PubMed ID: 21939765
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic targeting of regulatory T cells for solid organ transplantation: current and future prospects.
Safa K; Chandran S; Wojciechowski D
Drugs; 2015 Nov; 75(16):1843-52. PubMed ID: 26493288
[TBL] [Abstract][Full Text] [Related]
19. Kidney and liver organ transplantation in persons with human immunodeficiency virus: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(4):1-56. PubMed ID: 23074407
[TBL] [Abstract][Full Text] [Related]
20. Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity.
Romano M; Fanelli G; Albany CJ; Giganti G; Lombardi G
Front Immunol; 2019; 10():43. PubMed ID: 30804926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
